Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
about
Endometriosis-associated MalignancyMedical treatment of early stage and rare histological variants of epithelial ovarian cancerMolecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and TreatmentAn RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancerType-specific cell line models for type-specific ovarian cancer researchA Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian CancerIdentification of therapeutic targets applicable to clinical strategies in ovarian cancerOvercoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924Epithelial ovarian cancer - more data, more questions?A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian CancerOpportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.Cullin-1 promotes cell proliferation via cell cycle regulation and is a novel in prostate cancer.Towards identification of true cancer biomarkers.Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypesReduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathwayOvarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.Tubal origin of ovarian low-grade serous carcinoma.Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancerNapsin A as a marker of clear cell ovarian carcinoma.Estrogen biosynthesis and action in ovarian cancer.Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.Combination of rapamycin, CI-1040, and 17-AAG inhibits metastatic capacity of prostate cancer via Slug inhibition.Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21.Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells.Calycosin induces apoptosis in human ovarian cancer SKOV3 cells by activating caspases and Bcl-2 family proteins.MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinomaPTN signaling: Components and mechanistic insights in human ovarian cancer.Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas.Characteristics of Long-Term Survivors of Epithelial Ovarian CancerDifferences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma.Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells.'BRCAness' and its implications for platinum action in gynecologic cancer.Empirical chemosensitivity testing in a spheroid model of ovarian cancer using a microfluidics-based multiplex platform.Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological typeThe importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer.Targeting signaling pathways in epithelial ovarian cancer.Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel
P2860
Q26768656-12AA7A3F-986D-4E27-9EB6-1D0ED8BB9DBAQ26777702-F0A8E9DA-A3AE-4901-9864-13FEDDAAE243Q28066904-0AC840A7-110C-4751-BD64-023BC3790D91Q28484295-FB3F2159-FBD3-450A-9713-5DE62B9AF142Q28536689-1B86ADC3-A787-44B1-BD2F-FC77C8182038Q28551341-C3DBB87E-195F-4FC7-8F23-62D5583E7751Q28829029-F580F1C6-DDAA-4484-8F1A-A059D6F76012Q30410498-64215D4A-CC16-4A8A-A6A8-576A9A15C39EQ30869183-83BC5EF4-3B33-4624-8B29-A8A058F827BAQ33606561-43CBE579-8D4F-4CBF-85BF-0DE28A746B36Q33735161-814C040A-4B8E-4BCE-827D-9B70DCC2AAE8Q34043994-F9D68BAE-BA07-44AC-B70D-8F0EF958FE5AQ34168702-45FA5FA6-D83A-47FF-8AB9-DAB375F16E7AQ34199368-4CD83E4D-576A-40E0-8B0B-058F1DA7A8BFQ34233284-E5A6B88D-9863-4116-A04F-FC18B7F042B8Q34350701-659AEC49-997A-4DD3-8D83-B98A9F55E7B8Q34383567-2ECFD3B7-F042-4B1F-A6CE-B960A655A4F3Q34397197-7FB32DFB-6F95-49CB-B9C3-E78782B4E963Q34493304-E7B55A62-9515-4EAC-B68F-195DBB45AB39Q34496401-EAA1F8F6-678C-4034-A9D3-45E9A6411C93Q34738849-11048A58-75AF-47E0-A610-60C546AA97DBQ35018858-6DAE81D6-898C-463C-B6E7-322B81AB65ACQ35109273-BF4D3678-3295-40DF-8740-14FAB0BF12D6Q35149603-4467DDA8-DFF8-449A-84DA-A43ED4EC9810Q35232784-97162A88-E959-4533-A1FB-08E13F8FEAF6Q35559528-1364396F-950D-410D-9917-A7B676325D19Q35575822-A48EC5FE-CA2C-47C7-BD05-4A1482666AEAQ35685365-7D4364D6-A15F-42BE-BBDD-09A7E2322B8BQ35759295-8C2DD7C5-E900-44D8-B8D7-E7402E007685Q35864434-00048FA5-FA18-417B-BA8D-ACF62126E9FEQ35984294-FCC46ADB-DC46-45FB-A466-D869DC57EEE8Q35996897-1E7C00B0-7942-470A-855A-F07BD3096457Q36350112-F5793F5B-5930-43D4-BE25-2873F9DE5323Q36380704-159C8E55-0B9D-4F24-B885-7F613704E834Q36564821-307E9BB0-761E-4C48-AEBF-24D4B2B8E763Q36750564-068B2AF3-CDB2-43E7-85D6-092EEFA22E5CQ36799895-1294675A-1496-4A51-B302-AFA541182D4EQ36820568-50573D7B-F26A-4576-B93A-EB925C0F278BQ36913614-C39D534A-C8CD-4883-A0A6-05857031913CQ36975149-633200EA-4732-4EED-AE10-3D1F988DBCDD
P2860
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Morphological subtypes of ovar ...... developments and pathogenesis.
@en
Morphological subtypes of ovar ...... developments and pathogenesis.
@nl
type
label
Morphological subtypes of ovar ...... developments and pathogenesis.
@en
Morphological subtypes of ovar ...... developments and pathogenesis.
@nl
prefLabel
Morphological subtypes of ovar ...... developments and pathogenesis.
@en
Morphological subtypes of ovar ...... developments and pathogenesis.
@nl
P1433
P1476
Morphological subtypes of ovar ...... developments and pathogenesis.
@en
P2093
W Glenn McCluggage
P304
P356
10.1097/PAT.0B013E328348A6E7
P577
2011-08-01T00:00:00Z